Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)
Conditions: Non-Small-Cell Lung Cancer Interventions: Drug: Golidocitinib; Drug: Sintilimab; Drug: platinum doublet chemotherapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Dizal Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Acupuncture for Catheter-Related-Bladder Discomfort After Bladder Outlet Obstruction Surgery
Conditions: Catheter-related-bladder Discomfort Interventions: Other: Acupuncture; Other: Sham Acupuncture Sponsors: Guang ' anmen Hospital of China Academy of Chinese Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
Conditions: Breast Cancer, Familial Male; Radiotherapy; Complications; Chemotherapeutic Toxicity; Immune Checkpoint Inhibitor; CDK4/6 Inhibitor; Trastuzumab; Pertuzumab; PARP Inhibitor Interventions: Radiation: Chest wall / breast radiation with or without lymph node region radiation.(For all of the enrolled patients) Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
China National Study of Adrenal Venous Sampling
Conditions: Hyperaldosteronism Interventions: Procedure: adrenal venous sampling Sponsors: Chinese Academy of Medical Sciences, Fuwai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Lumeneye Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer
Conditions: Rectal Cancer Interventions: Device: International Cohort Sponsors: Bordeaux Colorectal Institute Academy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
Conditions: Thymus Neoplasms Interventions: Radiation: Adjuvant Hypofractionation Radiotherapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors
Conditions: Cancer; Malignant Neoplasm; Tumors; Metastatic Cancer Interventions: Diagnostic Test: 68Ga-DOTA-GPFAPI-04 PET/CT Sponsors: Guangdong Provincial People ' s Hospital; Shanghai Institute of Materia Medica, Chinese Academy of Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 1, 2024 Category: Research Source Type: clinical trials
RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations
Conditions: Non Small Cell Lung Cancer; ERBB2 Mutation-Related Tumors; ERBB2 Gene Duplication; Disitamab Vedotin Interventions: Drug: Disitamab Vedotin; Drug: third-generation EGFR TKIs (Almonertinib/Furmonertinib/Osimertinib); Drug: pyrotinib Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Polyamine Treatment in Elderly Patients With Coronary Artery Disease
Conditions: Ischemic Heart Disease; Myocardial Infarction; Cardiovascular Diseases; Vascular Diseases; Hypertensive Heart Disease; Hypertension; Diastolic Dysfunction; Obesity; Metabolic Syndrome; Diabetes Mellitus, Type 2; Dietary Habits; Inflammation; Quality of Life; Cognition Disorder; Cognitive Impairment Interventions: Dietary Supplement: Spermidine; Other: Placebo Sponsors: University of Aarhus; Sygesikringen Danmark; Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital; Danish Diabetes Academy; Danish Cardiovascular Academy (DCA); Eva and Henry Fr ænkels Mindefond Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
Conditions: Diphtheria; Tetanus; Pertussis Interventions: Biological: DTacP (one-dose booster); Biological: DTacP (three-dose primary vaccination); Biological: DT (one-dose booster); Biological: DTaP (one-dose booster); Biological: PENTAXIM (one-dose booster); Biological: DTaP (three-dose primary vaccination); Biological: PENTAXIM (three-dose primary vaccination) Sponsors: Institute of Medical Biology, Chinese Academy of Medical Sciences; Sichuan Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Superior Vena Cava Isolation Plus Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation
Conditions: Atrial Fibrillation Interventions: Procedure: Pulmonary vein isolation plus superior vena cava isolation; Procedure: Pulmonary vein isolation Sponsors: Chinese Academy of Medical Sciences, Fuwai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2023 Category: Research Source Type: clinical trials
Development of Attention and Its Relationship With Emotions in Children and Adolescents
Conditions: Attention Deficit Disorder With Hyperactivity Interventions: Device: a serious mobile device-based game prototype (Save the Muse Home) Sponsors: Institute of Psychology, Chinese Academy of Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
A Study of RC48-ADC Combined With Cadonilimab （AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma
Conditions: Urothelial Carcinoma Interventions: Drug: RC48-ADC; Drug: AK104 Sponsors: Shanxi Province Cancer Hospital; Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Effects of Low-Intensity Blood Flow Restriction Training in Normoxia and Hypoxia Conditions
Conditions: Hypoxia, Altitude; Blood Flow Restriction; Resistance Training Interventions: Other: low-intensity resistance training; Other: high-intensity resistance training; Other: low-intensity resistance training combined with blood flow restriction; Other: low-intensity resistance training in hypoxia condition; Other: low-intensity resistance training combined with blood flow restriction in hypoxia condition Sponsors: The Jerzy Kukuczka Academy of Physical Education in Katowice Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia
Conditions: Nosocomial Pneumonia; Community-acquired Pneumonia Interventions: Drug: 200 ppm Nitric Oxide; Drug: Sham treatment Sponsors: Tomsk National Research Medical Center of the Russian Academy of Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
